Stock A217480 SD BIOTECHNOLOGIES CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials SD Biotechnologies Co., Ltd.

Equities

A217480

KR7217480003

Personal Products

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 21/03/2023 GMT 		5-day change 1st Jan Change
500 KRW -4.90% Intraday chart for SD Biotechnologies Co., Ltd. +0.00% +0.00%
2023 SD Biotechnologies Co., Ltd. cancelled the transaction announced on January 26, 2023 CI
2023 SD Biotechnologies Co., Ltd. announced that it has received KRW 20 billion in funding from Sangsangin Investment & Securities Co.,Ltd. CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 195,459 110,955 106,359 71,616 53,046 14,870
Enterprise Value (EV) 1 204,407 121,060 118,677 125,422 98,742 18,361
P/E ratio 29.8 x -5.32 x -12.3 x -1.64 x -0.46 x -3.49 x
Yield - - - - - -
Capitalization / Revenue 1.25 x 0.71 x 0.76 x 0.57 x 0.57 x 0.32 x
EV / Revenue 1.31 x 0.77 x 0.84 x 1.01 x 1.06 x 0.39 x
EV / EBITDA 16.5 x -8.08 x -35.2 x -3.97 x -2.46 x -1.62 x
EV / FCF -5.91 x 27.8 x 58.7 x -7.54 x -3.43 x -0.82 x
FCF Yield -16.9% 3.6% 1.7% -13.3% -29.2% -122%
Price to Book 1.79 x 1.22 x 1.3 x 1.56 x 17.1 x 1.25 x
Nbr of stocks (in thousands) 15,646 15,646 15,646 15,646 29,154 29,741
Reference price 2 12,493 7,092 6,798 4,577 1,819 500.0
Announcement Date 18/03/19 19/03/20 19/03/21 21/03/22 22/03/23 28/03/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 156,624 156,259 140,725 124,681 92,860 46,943
EBITDA 1 12,384 -14,984 -3,367 -31,566 -40,172 -11,324
EBIT 1 10,345 -17,256 -6,789 -35,505 -46,228 -14,508
Operating Margin 6.61% -11.04% -4.82% -28.48% -49.78% -30.91%
Earnings before Tax (EBT) 1 8,347 -17,048 -9,235 -42,109 -74,954 -10,033
Net income 1 6,577 -18,445 -8,668 -43,567 -72,749 -4,608
Net margin 4.2% -11.8% -6.16% -34.94% -78.34% -9.82%
EPS 2 419.8 -1,332 -554.4 -2,785 -3,974 -143.5
Free Cash Flow 1 -34,610 4,358 2,021 -16,630 -28,816 -22,430
FCF margin -22.1% 2.79% 1.44% -13.34% -31.03% -47.78%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 18/03/19 19/03/20 19/03/21 21/03/22 22/03/23 28/03/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 8,948 10,106 12,318 53,806 45,696 3,491
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 0.7225 x -0.6744 x -3.658 x -1.705 x -1.138 x -0.3083 x
Free Cash Flow 1 -34,610 4,358 2,021 -16,630 -28,816 -22,430
ROE (net income / shareholders' equity) 5.51% -18.7% -10.7% -66.6% -279% -40.2%
ROA (Net income/ Total Assets) 4.65% -7.51% -2.99% -15.2% -23.8% -10.5%
Assets 1 141,510 245,749 289,573 287,356 305,811 43,849
Book Value Per Share 2 6,977 5,797 5,238 2,937 106.0 401.0
Cash Flow per Share 2 640.0 647.0 808.0 966.0 273.0 184.0
Capex 1 6,219 11,873 4,033 14,233 23,576 1,027
Capex / Sales 3.97% 7.6% 2.87% 11.42% 25.39% 2.19%
Announcement Date 18/03/19 19/03/20 19/03/21 21/03/22 22/03/23 28/03/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Cosmetics & Perfumes

1st Jan change Capi.
SD BIOTECHNOLOGIES CO., LTD. Stock SD Biotechnologies Co., Ltd.
+0.00% 10.9M
L'ORÉAL Stock L'Oréal
+1.36% 264B
KAO CORPORATION Stock Kao Corporation
+18.26% 20.44B
SHISEIDO COMPANY, LIMITED Stock Shiseido Company, Limited
+11.36% 12.29B
COTY INC. Stock Coty Inc.
-12.80% 9.5B
AMOREPACIFIC CORPORATION Stock Amorepacific Corporation
+16.55% 7.6B
PROYA COSMETICS CO.,LTD. Stock Proya Cosmetics Co.,Ltd.
+11.43% 6.16B
NATURA &CO HOLDING S.A. Stock Natura &Co Holding S.A.
-6.28% 4.24B
INTER PARFUMS, INC. Stock Inter Parfums, Inc.
-14.19% 3.92B
KOSÉ CORPORATION Stock KOSÉ Corporation
-7.58% 3.67B
Cosmetics & Perfumes
  1. Stock Market
  2. Equities
  3. A217480 Stock
  4. Financials SD Biotechnologies Co., Ltd.